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Abstract
Background: Intimate partner violence (IPV) during or before pregnancy is associated with many adverse health
outcomes. Pregnancy-related complications or poor infant health outcomes can arise from direct trauma as well as
physiological effects of stress, both of which impact maternal health and fetal growth and development. Antenatal
care can be a key entry point within the health system for many women, particularly in low-resource settings.
Interventions to identify violence during pregnancy and offer women support and counselling may reduce the
occurrence of violence and mitigate its consequences.
Methods: Following a formative research phase, a randomized controlled trial will be conducted to test a nurse-led
empowerment counselling intervention, originally developed for high-income settings and adapted for urban South
Africa. The primary outcome is reduction of partner violence, and secondary outcomes include improvement
in women’s mental health, safety and self-efficacy. The study aims to recruit 504 pregnant women from three
antenatal clinics in Johannesburg who will be randomized to the nurse-led empowerment arm (two 30-min
counselling sessions) or enhanced control condition (a referral list) to determine whether participants in the
intervention arm have better outcomes as compared to the those in the control arm.
Discussion: This research will provide much needed evidence on whether a short counselling intervention
delivered by nurses is efficacious and feasible in low resource settings that have high prevalence of IPV and HIV.
Trial registration: The study was registered in the South African Clinical Trials Registry (DOH-27-0414-4720) on 11
August 2014 and in the ISRCTN Registry (ISRCTN35969343) on 23 May 2016).
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Background
Violence against pregnant women is a global health con-
cern. Studies have documented prevalence rates of partner
violence during pregnancy ranging from 4–57 % globally
[1–3]. South African studies estimate that 25–35 % of
pregnant women experience past 12 month exposure to
physical or sexual violence from a partner [4–6].
Intimate partner violence (IPV) during or around the
time of pregnancy has been associated with many ad-
verse health outcomes for the pregnant woman and her
baby due to direct trauma, as well as physiological ef-
fects of stress from current or past violence that can im-
pact fetal growth and development. Previous research
has found that women experiencing violence during
pregnancy had higher rates of intrauterine growth re-
tardation and preterm labour [7–9], higher rates of mis-
carriage [10, 11], antepartum haemorrhage [12] and high
blood pressure [13]. Violence during pregnancy has also
been associated with maternal mortality [14] and peri-
natal, infant and child mortality [15, 16]. A recent sys-
tematic review and meta-analysis found that women
reporting IPV in pregnancy were more likely to have a
low birth weight infant and experience pre-term birth
[17]. In addition, intimate partner violence has been as-
sociated with increased rates of HIV infection and HIV
risk behaviour [18]. The maternal, infant, and reproduct-
ive health risks from intimate partner violence make it
imperative that violence against women be more fully
addressed during antenatal care.
Antenatal care can be a critical point of intervention
for women suffering violence. Globally, 83 % of women
have had at least one antenatal care visit [19], and even
in low-resource settings women attending only one or a
few antenatal care visits may benefit from an interven-
tion which can be provided in a single session and can
potentially reduce the occurrence of violence and miti-
gate its consequences. Other urgent health risks during
pregnancy, such as HIV/AIDS, STI prevention, and mal-
aria prophylaxis, are routinely addressed during antenatal
care, however, identification and response to violence dur-
ing pregnancy has not been routinely incorporated into
antenatal care despite its potentially serious consequences
and known adverse health outcomes. While the primary
outcome of the study is to reduce partner violence, we
also expect the intervention to have a positive impact on
the mental health, safety and self-efficacy of participants.
Some health care providers understand how women's
experiences of violence affect their health and the health
of their infants, and many in South Africa and elsewhere
have attempted to help their patients who are experien-
cing violence by a partner [20]. However, the evidence
base is still limited for intervention strategies in the
health sector and the antenatal care setting in particular.
Two studies in high-income settings found significant
positive results around a nurse-led antenatal interven-
tion for IPV [21, 22]. Others found promising or insig-
nificant results, although there was great variation in
intensity and content of the intervention, and small sam-
ple sizes meant insufficient power to detect differences
between groups [23].
While little evidence exists on effective interventions
to identify and address violence in the health sector in
low-resource settings, evidence from higher resource
settings has shown some elements of promising inter-
ventions that could be adapted and replicated in other
settings [24]. Empathetic listening is one of the most im-
portant elements of effective interventions to address
violence. This, combined with discussions about safety
planning and options for ending violence can be a valu-
able and empowering means of problem-solving and
building self-efficacy in this context [21–23, 25, 26].
Some studies have found that having a focal person at
the health centre who is specially trained on violence
and dedicated to the issue can be an important element
in responding to violence [27]; others identified support
groups as a potentially positive intervention option [28].
In general, research has confirmed the value of interven-
tions to address partner violence in antenatal care set-
tings and suggests that even a single counselling session
can result in improved safety behaviours and reduced
levels of intimate partner violence [21, 22].
South Africa is an ideal setting to test such an inter-
vention because of the high rates of antenatal care at-
tendance. More than 92 % of women have at least one
antenatal care visit and deliver with a skilled attendant
[29]. In addition, South Africa has a high burden of HIV
[30] and women with HIV are primarily identified in
antenatal care. Violence against women and gender in-
equality are closely linked with HIV risk through several
mechanisms. Violence or the threat of violence can limit
HIV prevention behaviours, and disclosure of HIV status
can provoke partner violence [31]. Therefore, it is crit-
ical that interventions to address violence against
women in antenatal care are linked with HIV counselling
and testing in South Africa as this study does.
Methods/Design
A randomized controlled trial (RCT) of a two-session
empowerment counselling intervention among pregnant
women (n = 504) experiencing past-year physical and/or
sexual IPV will be carried out at three antenatal clinics
in Johannesburg, South Africa. Individual women will be
randomized to the intervention or control group, with
women in the intervention group receiving the em-
powerment counselling intervention and women in the
control group receiving enhanced standard of care in the
form of a list of referrals to local resources.
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Objectives
The project aims to achieve the following objectives:
1. To test a nurse-led counselling intervention for
abused pregnant women receiving antenatal care in
South Africa that could be incorporated into the
routine antenatal care package.
2. To determine whether the counselling intervention
being tested during pregnancy can reduce the
recurrence of intimate partner violence and the
frequency and severity of this violence.
3. To determine whether the counselling intervention
being tested is effective in improving safety,
empowerment, mental health, and help- and health-
seeking behaviour of abused pregnant women.
4. To assess whether, at baseline, women experiencing
intimate partner violence differ from women who do
not experience intimate partner violence in regard
to mental health, self-efficacy, and HIV risk
behaviours.
5. To assess whether HIV-positive women who have
experienced intimate partner violence differ from
HIV-positive women who have not experienced
intimate partner violence with regard to PMTCT
uptake and adherence as measured at follow up.
The design of the randomized controlled trial was
adapted following a formative research stage described
elsewhere [32, 33], which included an assessment of the
current response to violence against women in both the
public and private sectors. Findings from the formative
research validated the importance of having an appropri-
ate response to violence against women in the clinic set-
ting, and informants (providers and pregnant women)
were supportive of the proposed intervention research
[33]. The formative stage included identification of the
organizations that respond to the health and psychosocial
needs of women experiencing violence; examination of
the current initiatives to address violence against women;
assessment of the technical capacity of health workers to
address violence and the barriers to implementation of a
health sector response at present.
To avoid disclosing the nature of the research and to
emphasize the focus on keeping women “safe” during
pregnancy and the postpartum period, the study was
named “Safe & Sound.”
The randomized controlled trial (RCT) will test the ef-
ficacy of an intervention to address partner violence dur-
ing pregnancy. Women screening positive for violence
and who satisfy the eligibility criteria will be randomized
to the intervention or control group (Fig. 1). The inter-
vention group will receive up to two sessions of a coun-
selling intervention and both groups will receive a
brief information sheet with local referrals, including
for counselling, shelters, legal resources, child protection
services, police, and other relevant NGOs. Each of the
listed referrals was contacted and its willingness and cap-
acity to respond to referrals during the course of this
study was assessed. Selected agencies will be included as
active referral options. The protocol complies with the
guidelines of the Standard Protocol Items: Recommenda-
tions for Interventional Trials (SPIRIT), and all data col-
lection is in compliance with Consolidated Standards of
Reporting Trials (CONSORT) guidelines.
At enrolment, data will be collected on socio-
demographic characteristics of participants, including
age, number of children, relationship and employment
status, education level, housing type, length of stay in
Johannesburg, socio-economic status and hunger index,
country of origin, as well as number of pregnancies and
live births for descriptive purposes and for potential in-
clusion in adjusted analyses.
Primary outcome
Intimate partner violence will be measured using a
modified version of the WHO instrument from the
Fig. 1 Study design provides a visual depiction of the study design
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WHO Multi-Country Study on Women’s Health and
Domestic Violence against Women [34]. This instru-
ment assesses women’s experience of physical, sexual,
and emotional violence as well as controlling behaviours
by a male intimate partner. The effect of the interven-
tion on the primary outcome of physical and/or sexual
intimate partner violence will be assessed by comparing
the percentage of women in the intervention vs. control
groups reporting acts of physical and/or sexual partner
violence during the study period and by analysing the
patterns of frequency and intensity of the violence be-
tween the two study groups based on follow up data.
Secondary outcomes
The two study arms will be compared on a number of
secondary outcomes measured at follow-up, including
mental health, safety planning, community resource use,
and self-efficacy. The Hospital Anxiety and Depression
Scale (HADS), a 21 question standardized instrument
measuring anxiety and depression, will be used to assess
the effect of the intervention on these mental health out-
comes [35]. A score of 8 or above is considered clinically
significant. An adapted version of the Safety Behavior
Checklist [36] will be used to calculate an average score
of safety behaviours used in the event of escalating vio-
lence. These include actions such as keeping an identity
card available, keeping a bag packed in case of escalating
violence, and removing knives or weapons from the
home. Self-efficacy will be measured using the General
Self-Efficacy Scale [37] and includes a set of questions
on beliefs and actions indicating feelings of personal
control over one’s life. Uptake of community resources,
particularly those included on the study referral sheet,
will also be assessed as a secondary study outcome by
comparing scores between study arms.
Sub-study outcomes
Two sub-studies will be linked to the RCT. One will assess
the role of IPV on the uptake and adherence to prevention
of mother-to-child transmission (PMTCT) among HIV-
positive women. This sub-study will compare HIV-related
outcomes in two groups of HIV-positive women: IPV-
positive women in the control group and IPV-negative
women who will be followed up for the purposes of this
sub-study. Adherence to antiretroviral therapy among
HIV-positive participants will be measured using the
30-day Visual Analog Scale (VAS). The VAS has been
validated in South Africa [38], and ‘good adherence’ will
be analysed using a cut-off of >95 % adherence. To fur-
ther assess PMTCT, self-report questions will be
adapted from a recent study among pregnant women in
Cape Town, South Africa [39]. Each step in the
PMTCT cascade will be analysed as a dichotomous
variable (completed step vs. not completed).
A second sub-study will compare at baseline socio-
demographic characteristics and mental health status
of women experiencing intimate partner violence to
those not experiencing partner violence to assess the
role of IPV status on women’s mental health prior to
enrolment in the study. These baseline measures will
include post-traumatic stress (using the Harvard Trauma
Questionnaire (HTQ) [40], anxiety and depression
status, and selected socio-demographic characteristics.
In addition, the association between IPV and selected
socio-demographic characteristics will be assessed to
determine which characteristics are associated with
IPV independent of the intervention.
Recruitment and randomization
Pregnant women will be screened for eligibility. Those
who are at least 18 years old and less than 33 weeks ges-
tation (to allow enough time for the second intervention
session) and who are able to communicate in one of the
most common local languages (English, Sotho, or Zulu)
will be eligible to participate in the randomized con-
trolled trial. Potential participants will also be asked if
they have experienced any of a number of forms of part-
ner violence in the past 12 months. Only those reporting
that they have experienced physical or sexual violence by
their current or most recent partner in the past
12 months will be eligible. Prior to being enrolled,
women will also be screened for immediate safety risk.
Reported risk of imminent lethal violence by a partner,
fear that a child in the home is at immediate risk of le-
thal violence by the partner, and being at suicidal risk
(as determined by having ideation with a plan to commit
suicide) will result in an immediate referral and disqual-
ify women from participating.
Women will be recruited during their routine ante-
natal appointments at primary healthcare clinics in
urban Johannesburg. All clinics are part of the district
public health service and generally serve very low in-
come communities. The study will be introduced by a
research nurse, who will provide a group introduction to
the study without identifying the study as being related
to violence but rather framing it as a study on women’s
health during pregnancy. A study flier will be distributed
with the name of the study and a phone number and
first name of the research nurse assigned to that clinic
site. Interested women will be offered an opportunity to
speak to nurses following their routine clinic care or to
schedule an appointment for another time.
Randomization will be conducted through block
randomization procedures with study arm assignment
revealed upon opening of sequential opaque sealed
envelopes prepared in Geneva by the Department of
Reproductive Health and Research, World Health
Organization. Study nurses will not be blinded to
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study arm; the same nurse who conducts the baseline
interview will also randomize eligible participants.
Sample size
The sample size needed to detect a difference in the pri-
mary outcome (IPV reduction) between the intervention
group and the control group will be 252 per group,
based on sample size calculations using results from pre-
vious studies testing a similar intervention in which a
difference of 7 % was detected between the intervention
and control group on intimate partner violence experi-
ence following the intervention [23].1 Nurse researchers
will be able to screen between one to five women per
clinic session. Based on previous studies [4], we estimate
that 25 % of women will report experiencing physical or
sexual violence from their partner in the last 12 months.
Nurse researchers will interview and randomize the eli-
gible participants as well as those who are not eligible
for the RCT but who are eligible for the sub-studies
based on responses in the baseline questionnaire.
Follow up
Women will be followed up either at their six weeks’
post-partum visit, when they come for their post-natal
check-up or immunization for their baby, by phone or at
a time arranged with the study nurse. An estimated 15 %
of loss to follow up is expected based on other studies in
this setting.
All women who experience an adverse event or serious
adverse event will be followed up until it is resolved or
she is in stable care. For the purposes of this study, an
adverse event will be defined as any untoward medical
occurrence or harmful event that affects the health or
well-being of a study participant or her infant while par-
ticipating in the study. A serious adverse event is defined
as any untoward medical occurrence or harmful event
that results in the death of a participant or her infant, is
life-threatening, requires inpatient hospitalization (other
than for routine delivery) or prolongation of existing
hospitalization, or results in persistent or significant
disability.
A recruitment period of 18 months with an additional
6 months of follow-up will be needed to recruit a suffi-
ciently large sample size, assuming exclusions for ineligi-
bility, refusal to participate, and loss to follow up.
The intervention
The Safe & Sound intervention is based on a nurse-led
"empowerment counselling model". This model has been
tested through randomized controlled studies in ante-
natal care and shown to be effective in improving
women's safety, coping, and potentially in reducing vio-
lence in the United States [21, 23] and Hong Kong [22].
The empowerment model assumes that the perpetration
of intimate partner violence aims to control the behav-
iour of female partners and that by increasing a woman's
sense of control over her life, she can better develop
strategies to reduce violence in her relationship [41].
This model promoted by Dutton [26] includes two com-
plementary components– (a) improving women's safety
and protection, including negotiating safer sex with a
partner, while (b) enhancing her decision-making and
problem solving ability in her relationship.
Safe & Sound is provided by a nurse researcher trained
in counselling and covers a combination of the following
elements that will be individually tailored depending on
women’s experience and her readiness to change:
 Empathetic listening; also called active listening or
reflective listening is a way of listening and
responding to another person that improves mutual
understanding and trust, including emotional
identification, compassion, feeling, and insight.
 Cyclical nature of partner violence: the nurse
researcher will discuss how abusive relationships
often follow predictable patterns in which abuse
might subside for a period of time, only to resume
again later. She will also discuss possible warning
signs that could indicate that a renewed phase of
violence might be imminent. By better
understanding these patterns, the woman should be
better prepared to prevent or reduce subsequent
violence and to predict signs of increased danger.
 Evaluating danger and discussing options: the
nurse will help the woman assess her level of risk in
her relationship with the violent partner and
whether there are signs that the violence will
escalate with potential health consequences for her
and her pregnancy. If the woman or her children are
in immediate danger for their life or if the woman
discloses suicidal ideation, she will not be part of the
study and will be referred appropriately, as discussed
previously. Based on the woman's current risk and
the support available to her, the nurse will discuss
options for reducing abuse, without providing
directives or value judgements. The nurse will
recognize that women cannot always safely leave
their abusive partners, but that they have options for
reducing abuse in their relationship. These options
include protecting children from violence,
developing safety strategies, accessing community
resources for social support, and addressing
relationship dynamics with partners.
 Developing safety strategies: the nurse will help
the woman to develop a safety strategy tailored to
her situation and based on culturally appropriate
actions for increasing personal safety of herself and
her children. These strategies include developing a
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code with family and friends to indicate increased
risk, alerting neighbours to the situation and seeking
support from them in the case of an abusive incident,
having a bag and documents ready in case of the need
to flee with children in the event of imminent danger.
Safety will also be discussed in relation to abused
women’s increased vulnerability to HIV or inability
to seek appropriate treatment among HIV positive
women, especially PMTCT. The nurse researcher
will help the woman identify those behaviours and
strategies that she can best implement.
 Pregnancy changes: based on early piloting of the
intervention which suggested women have concerns
around relationship and sexuality changes in
pregnancy, nurses can begin an open ended
discussion around participants’ pregnancy-related
concerns, including changes in relationship dynamics,
financial needs, or sexual desires that couples might
experience during the pregnancy and post-partum
period. The approach is to listen empathetically and
provide accurate health-related information to a
number of concerns (such as perceived danger of
sexual intercourse during pregnancy).
 Legal steps: women who are prepared to take legal
steps to protect themselves or their children from a
violent partner are given step-by-step instructions
for obtaining a protection order. In practice, this
process is complex and requires many visits to the
magistrate court and police. A ‘job aid’ developed with
input from a local legal organization specializing in
IPV will be employed. If needed, nurses can refer
women to legal aid for support in completing the
protection order.
 Available resources: based on the findings of the
formative research, participants will be given a list of
organizations or social services available locally that
can provide help with the psychological, legal, social,
shelter, or health-related needs resulting from
violence. All agencies will have been sensitized to
the study and have demonstrated capacity to
serve as referrals. The nurses will have a choice
of giving women a written, verbal, or telephone
referral to the external organizations, depending
on the preferences of the woman.
Training
The 30-h technical training of nurse researchers will be
carried out over a one-week period and will be based on
a training manual developed for the study, which will in-
clude a combination of presentations, participatory ac-
tivities, readings, reflections, and role-play exercises. The
following topics will be covered in the manual and train-
ing curriculum: improving knowledge and awareness
around intimate partner violence and how it links with
maternal and child health issues, and specifically with
HIV transmission and adherence to PMTCT; under-
standing the legal rights of women experiencing violence
in the study context; promoting mental health among
the study population; awareness of previous and current
trauma in the lives of participants; child protection ser-
vices and reporting obligations within the legal frame-
work; cycle of violence patterns; behaviour change and
assessing women’s readiness to change; safety planning;
community resources; self-care, relaxation, and dealing
with vicarious trauma. Clarifying values and perceptions
about violence based on individual or observed experi-
ences is also an important component of the training. A
trained clinical psychologist and social workers will be
available for counselling and discussion with the nurse
researchers in the event they feel the need for emotional
support or if they experience an emotional response to
the content of the training. The nurse researchers will
also be trained on the ethical and safety issues specific
to research on violence against women and how to iden-
tify and report on adverse events and serious adverse
events.
Weekly team meetings will offer a chance to debrief
about patient encounters and discuss relevant “case
studies”. This process will further familiarize nurses with
the components of the intervention and how to imple-
ment a second session. Throughout the discussion of
“case studies”, the study investigators will provide feed-
back to the team on how to implement the components
of the intervention in a standardized yet tailored man-
ner. Weekly meetings will also be an opportunity to
stress the importance of ensuring that participants ran-
domized to the control group are not intentionally or in-
advertently given components of the intervention, which
is a potential limitation in the study design. Group
supervision will be supplemented by a trained social
worker affiliated with the study, who can give guidance
to nurse researchers on patient care as needed.
Process evaluation
Process evaluations of clinical trials are important for
understanding and interpreting findings from a trial, in
particular why an intervention may or may not lead to
intended outcomes [42, 43]. A process evaluation will be
conducted over the course of the study to evaluate the
feasibility and safety of the intervention implementation,
the strengths and weaknesses of the intervention con-
tent, and the mechanisms through which the interven-
tion impacts outcomes. For this component, a mixed
methods approach will be used. Qualitative methods will
include in-depth interviews with participants, nurse re-
searchers and health workers in the study clinics; obser-
vations of the intervention sessions; structured reflection
diaries kept by nurse researchers; and review of meeting
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reports from team meetings with nurse researchers dis-
cussing study implementation. Quantitative methods will
include review of safety information from case report
forms, review of adverse event and serious adverse event
reports, analysis of intervention checklist reporting form
completed by nurses for each participant, analysis of
safety related questions in the database. The process
evaluation will explore the factors that helped or hin-
dered women’s uptake and use of the intervention, fac-
tors that helped the nurses provide the intervention
effectively, as well as improving understanding about the
pathways of change for women who responded to the
intervention. The practical considerations of implement-
ing a health sector based intervention will be assessed,
and the potential mechanisms of how the intervention
impacts change will also be explored.
Data management
Data collection will be done on paper case report forms
(CRFs) and data kept in locked cabinets until they are
transferred to the central office and reviewed in a data
quality check by the data manager. The data manager
will also compare responses in the screening logs with
responses in the CRFs to confirm the accuracy of the
screening logs. Since patient records are not kept at
clinics but rather are carried with them from appointment
to appointment, the screening logs and some components
of the CRFs will be considered source documents for
the trial. Screening logs and CRFs will be scanned
and uploaded to a secure location accessible by the
Geneva data management team. Data entry will occur
at WHO in Geneva. Open Clinica software [44] will
be used for data management.
The UNDP-UNFPA-UNICEF-WHO-World Bank Special
Programme of Research, Development and Research
Training in Human Reproduction (HRP) serves as spon-
sor for the study. Clinical studies supported by WHO are
carried out according to the International Conference on
Harmonization (ICH) Good Clinical Practice (GCP) stan-
dards, and WHO/HRP standard operating procedures
(WHO/HRP SOPs) in the design of the study, data collec-
tion, management, analysis, and interpretation of data.
HRP standard operating procedures (SOPs) for managing
clinical trials will be adhered to throughout the trial.
These procedures have been used in previous trials spon-
sored or coordinated by WHO. The roles and responsibil-
ities of all individuals and institutions involved in the
design and conduct of the study, including the study spon-
sor, study staff, study investigators, steering committee,
and the Data Safety and Monitoring Board (DSMB) are
clearly described in the SOPs. Data quality will be moni-
tored through 100 % visual checking of CRFs and screen-
ing logs at site by data manager and through additional
visual checks by the data analyst in Geneva. There will
also be query reporting once data are entered into the data
management system and through file reviews during regu-
lar monitoring visits.
Data will be analysed by study arm using an intention
to treat analysis and as detailed in a data analysis plan
developed for the study. Statistical data will be analysed
using Stata [45] and qualitative data from the process
evaluation will be analysed using NVivo [46].
Ethical and safety considerations
Researching violence against women can potentially re-
sult in unintentional risks to participants, researchers,
and other health personnel involved in the research. To
reduce risks, the study will follow strict ethical and
safety guidelines, based on the WHO recommendations
in Putting women first: ethical and safety recommenda-
tions for research on domestic violence against women
[47]. These include standard ethical measures on in-
formed consent, confidentiality, and voluntary participa-
tion, as well as additional measures related to risks in
conducting research on violence against women. For ex-
ample, nurse researchers are specially trained in inquir-
ing about violence experience sensitively and in a
supportive manner. They are expected to carry out all
interviews in total privacy and keep all information, in
particular intimate partner violence and HIV status of
women, confidential. They will also invite women to
keep their involvement in the study to themselves, to
avoid any safety risk from study participation. Any
mention of the study by the study team or clinic
nurses will describe the study as a study on women’s
health and safety during pregnancy. This type of lan-
guage prevents stigmatization of women participating
in the study. Referral networks have been established
so that women can seek additional services from or-
ganizations in the community.
All adverse events and serious adverse events re-
ported by participants or by clinic staff to study nurses
will be documented and reviewed by study investigators
to determine whether the event was unrelated or pos-
sibly, probably or highly probably related to IPV and to
study participation. All events will be followed up until
resolved and medical records will be sought when fur-
ther information is required. Those events deemed pos-
sibly, probably or highly probably related to study
participation will be escalated and reported to the Data
Safety and Monitoring Board (DSMB). The DSMB will
be comprised of a statistician, an epidemiologist and a
researcher specializing in gender-based violence and
will conduct periodic reviews of the data when 25 %,
50 %, 75 % and 100 % of the blinded follow up data of
the target sample is collected. They can request the
unblinding of the data and the discontinuation of the
study if warranted by the preliminary results. They will
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review monthly reports of adverse events and serious
adverse events and will review all adverse events or ser-
ious adverse events assessed by investigators as being”-
probably” or “highly probably” related to study
participation. The DSMB will advise on any protective
actions that should be taken.
Ethical clearance was granted by the Human Research
Ethics Committee of the University of the Witwatersrand,
Johannesburg, South Africa (M110832) and the Ethical
Review Committee of the World Health Organization in
Geneva, Switzerland (RPC471).
Discussion
The results of this study will provide much needed evi-
dence on how to address the needs of abused women in
an antenatal care package and on how to implement an
appropriate health sector response to violence against
women in low-resource settings. Testing an intervention
under controlled conditions to determine efficacy is an
important step prior to integrating it into a clinic setting
and determining how to implement it effectively. This
study is designed to test the efficacy of an intervention
and as such, dedicated research nurses will be hired and
trained to carry out the research aspects (e.g., determin-
ing eligibility, collecting data, randomizing eligible par-
ticipants) as well as the clinical aspects of implementing
the intervention or control conditions.
Several limitations should be noted. The overlapping
roles of research nurses in managing the research and
intervention aspects and the lack of blinding of study
nurses are important limitations in the study design.
Since nurses are trained in how to implement the inter-
vention it will potentially be difficult or professionally
distressing for them to maintain a control condition
throughout the study. This will be addressed thoroughly
in the training and team meetings.
It was decided that for ethical reasons the control
group would receive enhanced standard of care, a refer-
ral services list, rather than receiving standard level of
care, which in South Africa is presently nothing at all.
Women in the study may benefit from the referral list as
well as from the baseline encounter with the nurse in
which she inquires about her experiences of violence in
a kind, non-judgmental way. Inquiring about violence
exposure in the context of research may lead women to
contemplate the role of violence in their lives, which
could increase their awareness and recognition of the
problem and potentially influence outcomes [48]. These
conditions may reduce the relative difference in out-
comes between the intervention and control groups and
could bias results towards the null hypothesis. These
limitations will be monitored during the study through
the process evaluation and regular study monitoring to
understand their influence on the study outcomes.
Despite these limitations, the study will add important
evidence on the efficacy of a health sector intervention
to reduce partner violence in a context that urgently re-
quires practical intervention. As was confirmed in the
findings of the formative research stage, integrating this
type of intervention into antenatal care settings, particu-
larly with HIV- counselling and testing components,
would be an appropriate response in this setting. The
providers and patients interviewed confirmed that such
an intervention would be well received and could be an
important step in supporting women during pregnancy
to improve their health and that of their children.
Endnote
1Sample size calculations assume significance level = .05
and power = 80 %.
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